ANGIODYNAMICS INC (ANGO) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, ANGIODYNAMICS INC's filing signal continuing positive.

AngioDynamics, Inc. is a medical technology company focused on developing and selling products for cardiovascular disease and cancer diagnoses. The company operates through two segments: Med Tech, which includes its Auryon atherectomy system and thrombus management platform, and Med Device, which offers peripheral and vascular access products. AngioDynamics' strategy centers on innovative research and development, expanding clinical and regulatory pathways, and customer-focused sales. The company manufactures products primarily at its Queensbury, NY facility and also utilizes third-party manufacturers. AngioDynamics sells its products in the United States through a direct sales force and internationally via distributors.

Revenue is primarily driven by the sale of medical devices used in minimally invasive, image-guided procedures for vascular access, peripheral vascular disease treatment, and oncology and surgical applications. Key product lines contributing to revenue include the Auryon Atherectomy System, thrombus management platforms (AngioVac and AlphaVac), and the NanoKnife IRE Ablation System.